{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T23:29:05Z","timestamp":1768260545718,"version":"3.49.0"},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T00:00:00Z","timestamp":1138060800000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Psoriasis commonly affects children and adolescents, and the need for safe, effective therapy is a special consideration in the pediatric population. In recent years, the use of targeted immunomodulatory biologic agents has been increasingly studied for the treatment of psoriasis. Of these, etanercept, a tumor necrosis factor\u2010\u03b1 antagonist, has been approved for the treatment of psoriasis and psoriatic arthritis in adults, and while it is approved for use in juvenile rheumatoid arthritis, formal studies are needed to demonstrate its safety and efficacy for childhood psoriasis. We present our preliminary experience of treating nine pediatric patients with generalized, recalcitrant psoriasis with etanercept therapy.<\/jats:p>","DOI":"10.1111\/j.1525-1470.2006.00174.x","type":"journal-article","created":{"date-parts":[[2006,1,24]],"date-time":"2006-01-24T12:32:55Z","timestamp":1138105975000},"page":"67-71","source":"Crossref","is-referenced-by-count":31,"title":["Etanercept for Psoriasis in the Pediatric Population: Experience in Nine Patients"],"prefix":"10.1111","volume":"23","author":[{"given":"Aimee C.","family":"Hawrot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise W.","family":"Metry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy J.","family":"Theos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moise L.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,24]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00832.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2000.01746.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1470.2001.018003188.x"},{"key":"e_1_2_5_5_2","first-page":"309","article-title":"Childhood psoriasis","volume":"64","author":"Farber EM","year":"1999","journal-title":"Cutis"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(03)01136-8"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)80057-7"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038164"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07536-0"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2002.5289"},{"key":"e_1_2_5_11_2","first-page":"10","article-title":"Etanercept (Enbrel) \u2013 an update","volume":"9","author":"Goffe B.","year":"2005","journal-title":"Skin Ther Lett"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030409"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02530-7"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-0963.2001.04529.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0736-8046.2004.21121.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003163421103"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","unstructured":"HorneffG SchmellingH BiedermannTet al.The German etanercept registry for treatment of juvenile idiopathic arthritis (JIA).Ann Rheum Dis2004;63:16381644(Epub 2004 April).","DOI":"10.1136\/ard.2003.014886"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.3.245"},{"key":"e_1_2_5_19_2","first-page":"723","article-title":"Etanercept in systemic juvenile idiopathic arthritis","volume":"20","author":"Russo RA","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.07.043"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10710"},{"key":"e_1_2_5_22_2","unstructured":"Etanercept package insert."},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2004.02.003"},{"key":"e_1_2_5_24_2","unstructured":"KavanaughA CushJJ MattesonE.FDA Meeting March 2003: update on the safety of new drugs for rheumatoid arthritis. Part II: CHF infection and other safety issues [WWW document]. URLhttp:\/\/www.rheumatology.org\/publications\/hotline\/0803chf.asp?aud=mem[accessed on April 2005]."},{"key":"e_1_2_5_25_2","unstructured":"CushJJ KavanaughA.FDA Meeting March 2003: update on the safety of new drugs for rheumatoid arthritis [WWW document]. URLhttp:\/\/www.rheumatology.org\/publications\/hotline\/0303TNFL.asp?aud=mem[accessed April 2005]."}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1470.2006.00174.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1470.2006.00174.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T08:29:42Z","timestamp":1697099382000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1470.2006.00174.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1525-1470.2006.00174.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1470.2006.00174.x","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}